Sonata Articles
King's 2nd-qtr revenue rises 9%, net income falls
20 August 2007
King's 1st-qtr 2007 revenue increases 7%
21 May 2007
King sees 1st-qtr earnings drop 28% to $51M
29 May 2006
Stock Commentary - New York week to Mar 6, 2006
13 March 2006
Teva gets tentative US OK for generic zaleplon
5 December 2005
Takeda R&D meeting focuses on insomnia treatment Rozeram
1 August 2005
King's 3rd-qtr profit plunges, may restate
8 November 2004
UK NICE guidance on insomnia drugs
10 May 2004
King 2003 revenues up 35%, but earnings slip
1 March 2004
Elan reports 34% drop in 2003 turnover
23 February 2004
King reins in 2003 profit forecasts
10 November 2003
Elan losses narrow but revenues plunge 46%
22 September 2003
King completes Elan acquisition at discount
23 June 2003
FTC drops enquiry into Elan's Skelaxin
19 May 2003
Stock Commentary - New York
12 May 2003
Lost revenues hit Elan as losses widen further
12 May 2003
Eon gets "no go" on generic Skelaxin
31 March 2003
King Pharma revises forecasts after Elan unit acquisitions
10 February 2003
Sepracor seeks US OK for eszopiclone
10 February 2003
Elan recovery plan on track to settle debts
10 February 2003
Elan sells franchise to King for $850M
3 February 2003
Elan sued by Pharma Marketing over Sonata royalties
27 January 2003
Strong earnings growth for Ireland's Elan on healthy US sales
11 February 2002
AHP and Elan alliance for sleep disorders
7 January 2002
AHP and Elan alliance for sleep disorders
20 December 2001
Wyeth and Lundbeck link up for Sonata
24 February 2000
Busy year for NCEs as major new compound classes launched
6 January 2000
Wyeth-Lederle withdraws RotaShield vaccine - updated story
21 October 1999
AHP weathers the storm with first Rapamune approval
17 September 1999
AHP close to settling $3 billion lawsuits?
17 September 1999
Wyeth-Ayerst's Sonata backed by FDA
17 August 1999
First launch of AHP's Sonata for insomnia
20 May 1999
Non-Merger Of AHP - Plus For Synthelabo
2 November 1998
Strong First Six Months For Synthelabo
30 June 1998
Wyeth Files For New Hypnotic In USA
26 February 1998
Showing 1-49 of 49 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
